This page lists the SEC filings reported by Eventide Asset Management.
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2023-02-14 | EVENTIDE ASSET MANAGEMENT, LLC | Annexon, Inc. | 3,626,508 | 7.6% | EDGAR |
| SC 13G/A | 2023-02-14 | EVENTIDE ASSET MANAGEMENT, LLC | Cogent Biosciences, Inc. | 2,589,778 | 3.7% | EDGAR |
| SC 13G/A | 2023-02-14 | EVENTIDE ASSET MANAGEMENT, LLC | Freeline Therapeutics Holdings plc | 5,920,765 | 9.1% | EDGAR |
| SC 13G/A | 2023-02-14 | EVENTIDE ASSET MANAGEMENT, LLC | Prometheus Biosciences, Inc. | 1,032,938 | 2.2% | EDGAR |
| SC 13G/A | 2023-02-14 | EVENTIDE ASSET MANAGEMENT, LLC | VectivBio Holding AG | 3,405,644 | 5.4% | EDGAR |
| SC 13G/A | 2023-02-14 | EVENTIDE ASSET MANAGEMENT, LLC | Zymeworks Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2023-02-14 | EVENTIDE ASSET MANAGEMENT, LLC | ESSA Pharma Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2023-02-14 | EVENTIDE ASSET MANAGEMENT, LLC | SUTRO BIOPHARMA, INC. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2023-02-14 | EVENTIDE ASSET MANAGEMENT, LLC | Vital Farms, Inc. | 0 | 0.0% | EDGAR |
| SC 13G | 2023-02-14 | EVENTIDE ASSET MANAGEMENT, LLC | 908 Devices Inc. | 2,230,665 | 7.0% | EDGAR |
| SC 13G | 2023-02-14 | EVENTIDE ASSET MANAGEMENT, LLC | Aura Biosciences, Inc. | 2,251,368 | 6.3% | EDGAR |
| SC 13G | 2023-02-14 | EVENTIDE ASSET MANAGEMENT, LLC | MARINUS PHARMACEUTICALS, INC. | 3,150,000 | 6.6% | EDGAR |
| SC 13G | 2023-02-14 | EVENTIDE ASSET MANAGEMENT, LLC | Mirum Pharmaceuticals, Inc. | 2,057,000 | 5.6% | EDGAR |
| SC 13G/A | 2022-02-14 | EVENTIDE ASSET MANAGEMENT, LLC | Annexon, Inc. | 2,850,000 | 7.4% | EDGAR |
| SC 13G/A | 2022-02-14 | EVENTIDE ASSET MANAGEMENT, LLC | Entasis Therapeutics Holdings Inc. | 590,602 | 1.2% | EDGAR |
| SC 13G/A | 2022-02-14 | EVENTIDE ASSET MANAGEMENT, LLC | ESSA Pharma Inc. | 3,318,647 | 7.5% | EDGAR |
| SC 13G/A | 2022-02-14 | EVENTIDE ASSET MANAGEMENT, LLC | Freeline Therapeutics Holdings plc | 3,485,656 | 9.7% | EDGAR |
| SC 13G/A | 2022-02-14 | EVENTIDE ASSET MANAGEMENT, LLC | Kala Pharmaceuticals, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2022-02-14 | EVENTIDE ASSET MANAGEMENT, LLC | KalVista Pharmaceuticals, Inc. | 138,821 | 0.6% | EDGAR |
| SC 13G/A | 2022-02-14 | EVENTIDE ASSET MANAGEMENT, LLC | PLIANT THERAPEUTICS, INC. | 42,499 | 0.1% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.